Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

4.8K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.8K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

3.4K
3.4K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

22.9K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
22.9K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

3.2K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.2K
Stem Cell Culture01:17

Stem Cell Culture

4.5K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
4.5K
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Machine learning approach to analyzing complex care coordination patterns for medically complex children.

BMC medical informatics and decision making·2026
Same author

Sustained efficacy and long-term outcomes of autologous oral mucosal epithelial cell sheet transplantation for pediatric esophageal anastomotic restenosis.

Scientific reports·2026
Same author

The Expression of Placental 17β-Hydroxysteroid Dehydrogenase Genes Is Associated with the Elevation of Active Androgens and Estrogens in Pregnant Women, but Does Not Affect 11-Oxygenated C19 Steroids.

International journal of molecular sciences·2026
Same author

In-utero cell transplantation for hypophosphatasia with gene-edited hESC-derived MSCs in a murine model.

Molecular therapy. Advances·2026
Same author

The feasibility of human embryonic stem cell (hESC)-derived cartilage for tracheoplasty.

Regenerative therapy·2025
Same author

Generation of implant-type tissue-engineered cartilage from human embryonic stem cell-derived chondrocytes.

Regenerative therapy·2025

Related Experiment Video

Updated: Apr 26, 2026

Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System
08:00

Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System

Published on: May 14, 2015

34.5K

A practical guide to induced pluripotent stem cell research using patient samples.

Katherine E Santostefano1, Takashi Hamazaki2, Nikolett M Biel1

  • 1Department of Pathology, Immunology and Laboratory Medicine, Center for Cellular Reprogramming, University of Florida College of Medicine, Gainesville, FL, USA.

Laboratory Investigation; a Journal of Technical Methods and Pathology
|August 5, 2014
PubMed
Summary

Patient induced pluripotent stem cells (iPSCs) are valuable for disease research but face challenges in differentiation and in vitro relevance. New methods like organoids and xenotransplantation aim to overcome these limitations for better human pathobiology insights.

More Related Videos

A Guide to Generating and Using hiPSC Derived NPCs for the Study of Neurological Diseases
09:30

A Guide to Generating and Using hiPSC Derived NPCs for the Study of Neurological Diseases

Published on: February 21, 2015

17.8K
Induced Pluripotent Stem Cell Generation from Blood Cells Using Sendai Virus and Centrifugation
09:57

Induced Pluripotent Stem Cell Generation from Blood Cells Using Sendai Virus and Centrifugation

Published on: December 21, 2016

14.3K

Related Experiment Videos

Last Updated: Apr 26, 2026

Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System
08:00

Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System

Published on: May 14, 2015

34.5K
A Guide to Generating and Using hiPSC Derived NPCs for the Study of Neurological Diseases
09:30

A Guide to Generating and Using hiPSC Derived NPCs for the Study of Neurological Diseases

Published on: February 21, 2015

17.8K
Induced Pluripotent Stem Cell Generation from Blood Cells Using Sendai Virus and Centrifugation
09:57

Induced Pluripotent Stem Cell Generation from Blood Cells Using Sendai Virus and Centrifugation

Published on: December 21, 2016

14.3K

Area of Science:

  • Biomedical Research
  • Pathobiology
  • Stem Cell Biology

Background:

  • Patient-derived induced pluripotent stem cells (iPSCs) have emerged as a significant tool in biomedical research.
  • The concept of 'disease in a dish' modeling using iPSCs is gaining traction, comparable to established models like knockout mice.
  • Despite advancements, practical limitations hinder the widespread application of iPSCs for comprehensive disease mechanism studies.

Purpose of the Study:

  • To review the genuine contributions of patient iPSC research to understanding human pathobiology.
  • To identify and discuss current technological limitations in iPSC applications.
  • To provide practical guidance for leveraging iPSC resources effectively in experimental pathology.

Main Methods:

  • Summarizing existing literature on patient iPSC studies.
  • Analyzing challenges in iPSC differentiation and in vitro model relevance.
  • Highlighting novel approaches such as 3D organoid cultures, xenotransplantation, and co-culture systems.

Main Results:

  • Patient iPSC studies have yielded valuable insights into disease mechanisms, despite initial skepticism.
  • Key challenges include efficient directed differentiation and ensuring in vitro outcomes accurately reflect in vivo disease conditions.
  • Emerging technologies show promise in overcoming current obstacles and enhancing the utility of iPSCs.

Conclusions:

  • Patient iPSCs are a powerful asset for experimental pathology and understanding human diseases.
  • Continued technological innovation is crucial for maximizing the potential of iPSC-based disease modeling.
  • Strategic utilization of iPSC resources will shape the future of pathobiology research.